Erythra-Derm en es it fr

Erythra-Derm Brand names, Erythra-Derm Analogs

Erythra-Derm Brand Names Mixture

  • No information avaliable

Erythra-Derm Chemical_Formula


Erythra-Derm RX_link

No information avaliable

Erythra-Derm fda sheet

Erythra-Derm msds (material safety sheet)

Erythra-Derm Synthesis Reference

No information avaliable

Erythra-Derm Molecular Weight

167.205 g/mol

Erythra-Derm Melting Point

96 oC

Erythra-Derm H2O Solubility

2500 mg/L

Erythra-Derm State


Erythra-Derm LogP


Erythra-Derm Dosage Forms

No information avaliable

Erythra-Derm Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

Erythra-Derm Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

Erythra-Derm Absorption

Rapidly absorbed following oral administration.

Erythra-Derm side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

Erythra-Derm Patient Information

Erythra-Derm Organisms Affected

Humans and other mammals